- Home
- TWST vs MIAX Comparison
TWST vs MIAX Comparison
Compare TWST & MIAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TWST
- MIAX
- Stock Information
- Founded
- TWST 2013
- MIAX 2007
- Country
- TWST United States
- MIAX United States
- Employees
- TWST N/A
- MIAX N/A
- Industry
- TWST Biotechnology: Biological Products (No Diagnostic Substances)
- MIAX Investment Bankers/Brokers/Service
- Sector
- TWST Health Care
- MIAX Finance
- Exchange
- TWST Nasdaq
- MIAX Nasdaq
- Market Cap
- TWST 2.3B
- MIAX 2.5B
- IPO Year
- TWST 2018
- MIAX 2025
- Fundamental
- Price
- TWST $25.76
- MIAX $35.00
- Analyst Decision
- TWST Buy
- MIAX
- Analyst Count
- TWST 9
- MIAX 0
- Target Price
- TWST $50.67
- MIAX N/A
- AVG Volume (30 Days)
- TWST 1.6M
- MIAX 2.4M
- Earning Date
- TWST 08-04-2025
- MIAX 01-01-0001
- Dividend Yield
- TWST N/A
- MIAX N/A
- EPS Growth
- TWST N/A
- MIAX N/A
- EPS
- TWST N/A
- MIAX 0.02
- Revenue
- TWST $362,273,000.00
- MIAX $1,255,413,000.00
- Revenue This Year
- TWST $22.28
- MIAX N/A
- Revenue Next Year
- TWST $17.40
- MIAX N/A
- P/E Ratio
- TWST N/A
- MIAX $1,681.44
- Revenue Growth
- TWST 22.72
- MIAX 19.63
- 52 Week Low
- TWST $24.28
- MIAX $28.63
- 52 Week High
- TWST $55.33
- MIAX $38.44
- Technical
- Relative Strength Index (RSI)
- TWST 36.12
- MIAX N/A
- Support Level
- TWST $24.97
- MIAX N/A
- Resistance Level
- TWST $27.29
- MIAX N/A
- Average True Range (ATR)
- TWST 1.23
- MIAX 0.00
- MACD
- TWST 0.10
- MIAX 0.00
- Stochastic Oscillator
- TWST 20.73
- MIAX 0.00
About TWST Twist Bioscience Corporation
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.